27600000 27600000 27600000 23454945 6900000 6900000 6900000 6900000 0001837607--12-31 2022 Q3 false 0 0 0 0 6900000 6900000 0 0 0 0 0 0 6900000 6900000 27600000 6900000 27600000 6900000 27600000 6900000 23454945 6900000 0.05 0.16 0.18 0.26 0.05 0.16 0.18 0.26 5520000 14975165 0.05 0.05 0.18 0.18 0.16 0.16 0.26 0.26 0.33 P3D 6900000 0001837607 us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-09-30 0001837607 us-gaap:MeasurementInputPriceVolatilityMember 2022-09-30 0001837607 us-gaap:MeasurementInputExpectedTermMember 2022-09-30 0001837607 us-gaap:MeasurementInputExpectedDividendRateMember 2022-09-30 0001837607 us-gaap:MeasurementInputExercisePriceMember 2022-09-30 0001837607 pmgmu:MarketImpliedLikelihoodOfIbcMember 2022-09-30 0001837607 us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001837607 us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001837607 us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001837607 us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-31 0001837607 us-gaap:MeasurementInputExercisePriceMember 2021-12-31 0001837607 pmgmu:CommonClassaSubjectToRedemptionMember 2022-09-30 0001837607 pmgmu:CommonClassaSubjectToRedemptionMember 2021-12-31 0001837607 us-gaap:RetainedEarningsMember 2022-09-30 0001837607 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001837607 us-gaap:RetainedEarningsMember 2022-06-30 0001837607 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001837607 2022-06-30 0001837607 us-gaap:RetainedEarningsMember 2022-03-31 0001837607 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001837607 2022-03-31 0001837607 us-gaap:RetainedEarningsMember 2021-12-31 0001837607 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001837607 us-gaap:RetainedEarningsMember 2021-09-30 0001837607 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001837607 us-gaap:RetainedEarningsMember 2021-06-30 0001837607 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001837607 2021-06-30 0001837607 us-gaap:RetainedEarningsMember 2021-03-31 0001837607 2021-03-31 0001837607 us-gaap:RetainedEarningsMember 2020-12-31 0001837607 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001837607 2020-12-31 0001837607 pmgmu:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member 2022-09-30 0001837607 pmgmu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001837607 pmgmu:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001837607 pmgmu:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001837607 us-gaap:OverAllotmentOptionMember 2021-02-11 0001837607 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-09-30 0001837607 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001837607 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001837607 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001837607 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-09-30 0001837607 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-06-30 0001837607 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001837607 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-31 0001837607 pmgmu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member pmgmu:PublicWarrantsMember 2022-09-30 0001837607 pmgmu:PublicWarrantsMember us-gaap:CommonClassAMember 2022-09-30 0001837607 pmgmu:SponsorMember 2021-02-11 2021-02-11 0001837607 pmgmu:FounderSharesMember pmgmu:SponsorMember us-gaap:CommonClassBMember 2020-12-17 2020-12-17 0001837607 pmgmu:AdministrativeServiceFeeMember 2022-07-01 2022-09-30 0001837607 pmgmu:AdministrativeServiceFeeMember 2022-01-01 2022-09-30 0001837607 pmgmu:AdministrativeServiceFeeMember 2021-07-01 2021-09-30 0001837607 pmgmu:AdministrativeServiceFeeMember 2021-01-01 2021-09-30 0001837607 pmgmu:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2021-02-11 2021-02-11 0001837607 pmgmu:PromissoryNoteWithRelatedPartyMember 2022-09-30 0001837607 pmgmu:PromissoryNoteWithRelatedPartyMember 2021-12-31 0001837607 pmgmu:SponsorMember 2021-02-11 0001837607 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001837607 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001837607 2022-04-01 2022-06-30 0001837607 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001837607 2022-01-01 2022-03-31 0001837607 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001837607 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001837607 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001837607 us-gaap:FairValueInputsLevel3Member 2022-09-30 0001837607 us-gaap:FairValueInputsLevel3Member 2022-06-30 0001837607 us-gaap:FairValueInputsLevel3Member 2022-03-31 0001837607 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001837607 us-gaap:FairValueInputsLevel3Member 2021-09-30 0001837607 us-gaap:FairValueInputsLevel3Member 2021-06-30 0001837607 us-gaap:FairValueInputsLevel3Member 2021-03-31 0001837607 us-gaap:FairValueInputsLevel3Member 2021-02-10 0001837607 us-gaap:FairValueInputsLevel3Member 2022-07-01 2022-09-30 0001837607 us-gaap:FairValueInputsLevel3Member 2022-04-01 2022-06-30 0001837607 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-03-31 0001837607 us-gaap:FairValueInputsLevel3Member 2021-07-01 2021-09-30 0001837607 us-gaap:FairValueInputsLevel3Member 2021-02-11 2021-03-31 0001837607 us-gaap:FairValueInputsLevel3Member 2021-04-01 2021-06-30 0001837607 us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001837607 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001837607 us-gaap:CommonClassBMember 2021-07-01 2021-09-30 0001837607 us-gaap:CommonClassAMember 2021-07-01 2021-09-30 0001837607 us-gaap:CommonClassBMember 2021-01-01 2021-09-30 0001837607 us-gaap:CommonClassAMember 2021-01-01 2021-09-30 0001837607 pmgmu:CommonClassaNotSubjectToRedemptionMember 2022-09-30 0001837607 pmgmu:CommonClassaNotSubjectToRedemptionMember 2021-12-31 0001837607 us-gaap:CommonClassBMember 2021-02-08 0001837607 us-gaap:CommonClassAMember 2022-09-30 0001837607 us-gaap:CommonClassBMember 2021-12-31 0001837607 us-gaap:CommonClassAMember 2021-12-31 0001837607 pmgmu:FounderSharesMember pmgmu:SponsorMember us-gaap:CommonClassBMember 2020-12-17 0001837607 pmgmu:PublicWarrantsMember us-gaap:CommonClassAMember us-gaap:IPOMember 2021-02-11 0001837607 us-gaap:WarrantMember 2022-09-30 0001837607 pmgmu:PublicWarrantsMember us-gaap:IPOMember 2021-02-11 0001837607 pmgmu:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2021-02-11 0001837607 us-gaap:CommonClassAMember 2021-02-08 0001837607 2021-09-30 0001837607 us-gaap:CashMember 2022-09-30 0001837607 us-gaap:CashMember 2021-12-31 0001837607 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001837607 2021-01-01 2021-03-31 0001837607 pmgmu:WorkingCapitalLoanMember 2021-12-31 0001837607 us-gaap:OverAllotmentOptionMember 2021-02-11 2021-02-11 0001837607 pmgmu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member pmgmu:PrivatePlacementWarrantsMember 2022-01-01 2022-09-30 0001837607 pmgmu:FounderSharesMember pmgmu:SponsorMember us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001837607 pmgmu:AdministrativeServiceFeeMember pmgmu:SponsorMember 2021-02-08 2021-02-08 0001837607 pmgmu:AdministrativeServiceFeeMember pmgmu:CeoAndCfoMember 2021-02-08 2021-02-08 0001837607 pmgmu:AdministrativeServiceFeeMember 2021-02-08 2021-02-08 0001837607 us-gaap:IPOMember 2021-02-11 2021-02-11 0001837607 pmgmu:PublicWarrantsMember us-gaap:IPOMember 2021-02-11 2021-02-11 0001837607 pmgmu:FounderSharesMember pmgmu:SponsorMember us-gaap:CommonClassBMember 2021-02-08 0001837607 pmgmu:PublicWarrantsMember us-gaap:CommonClassAMember us-gaap:IPOMember 2021-02-11 2021-02-11 0001837607 pmgmu:WorkingCapitalLoanMember us-gaap:NoteWarrantMember 2021-09-30 0001837607 pmgmu:PromissoryNoteWithRelatedPartyMember 2020-12-17 2020-12-17 0001837607 2021-12-31 0001837607 us-gaap:IPOMember 2021-02-11 0001837607 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001837607 us-gaap:IPOMember 2022-09-30 0001837607 us-gaap:CommonClassBMember 2022-09-30 0001837607 2021-01-01 2021-12-31 0001837607 pmgmu:PublicWarrantsMember us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001837607 pmgmu:WorkingCapitalLoanMember 2022-09-30 0001837607 pmgmu:PrivatePlacementWarrantsMember us-gaap:OverAllotmentOptionMember 2021-02-11 0001837607 pmgmu:PrivatePlacementWarrantsMember us-gaap:IPOMember 2021-02-11 0001837607 2022-07-01 2022-09-30 0001837607 2021-07-01 2021-09-30 0001837607 2021-01-01 2021-09-30 0001837607 pmgmu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member pmgmu:PublicWarrantsMember 2022-01-01 2022-09-30 0001837607 pmgmu:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member us-gaap:WarrantMember 2022-01-01 2022-09-30 0001837607 2022-09-30 0001837607 us-gaap:USTreasurySecuritiesMember 2022-09-30 0001837607 us-gaap:USTreasurySecuritiesMember 2021-12-31 0001837607 2021-02-11 2021-02-11 0001837607 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001837607 2021-04-01 2021-06-30 0001837607 pmgmu:PromissoryNoteWithRelatedPartyMember 2021-01-13 2021-01-13 0001837607 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001837607 pmgmu:UnitsEachConsistingOfOneShareOfCommonStockAndOneThirdOfOneRedeemableWarrantMember 2022-01-01 2022-09-30 0001837607 pmgmu:RedeemableWarrantsExercisableForClassCommonStockMember 2022-01-01 2022-09-30 0001837607 us-gaap:CommonClassBMember 2022-11-14 0001837607 us-gaap:CommonClassAMember 2022-11-14 0001837607 2022-01-01 2022-09-30 xbrli:shares iso4217:USD xbrli:pure iso4217:USD xbrli:shares pmgmu:D pmgmu:Vote pmgmu:item pmgmu:Y

Table of Contents

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

​

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2022

OR

​

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to.

​
Priveterra Acquisition Corp.
(Exact name of registrant as specified in its charter)

​

​

​ | ​ | ​ | ​ | ​
Delaware |  | 001-39945 |  | 85-3940478
(State or other jurisdiction of incorporation) | ​ | (Commission File Number) |  | (I.R.S. Employer Identification Number)

​

300 SE 2nd Street, Suite 600

Fort Lauderdale, FL 33301

(754) 220-9229

Registrant’s Telephone Number, Including Area Code

Not Applicable

(Former name or former address, if changed since last report)

​

Securities registered pursuant to Section 12(b) of the Act:

​ | ​ | ​ | ​ | ​
Title of each class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Class A common stock, par value $0.0001 per share |  | PMGM |  | The Nasdaq Stock Market LLC
Redeemable warrants, each warrant exercisable for one share of Class A common stock at an exercise price of $11.50 |  | PMGMW |  | The Nasdaq Stock Market LLC
Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant |  | PMGMU |  | The Nasdaq Stock Market LLC

​

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

​

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

​

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

​

​ | ​ | ​ | ​
Large accelerated filer | ☐ | Accelerated filer | ☐
Non-accelerated filer | ☒ | Smaller reporting company | ☒
Emerging growth company | ☒ | ​ | ​

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

​

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

​

As of November 14, 2022, 27,600,000 shares of Class A common stock, par value $0.0001 per share, and 6,900,000 shares of Class B common stock, par value $0.0001 per share, were issued and outstanding, respectively.

​

​

​

​

Table of Contents

PRIVETERRA ACQUISITION CORP.

Form 10-Q

For the Quarter Ended September 30, 2022

Table of Contents

​

​ | Page
PART I. FINANCIAL INFORMATION | 3
Item 1. Financial Statements. | 3
Condensed Balance Sheets as of September 30, 2022 (unaudited) and December 31, 2021 | 3
Unaudited Condensed Statements of Operations for the three and nine months ended September 30, 2022 and 2021 | 4
Unaudited Condensed Statements of Changes in Stockholders’ Deficit for the three and nine months ended September 30, 2022 and 2021 | 5
Unaudited Condensed Statements of Cash Flows for the nine months ended September 30, 2022 and 2021 | 6
Notes to Condensed Financial Statements | 7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. | 21
Item 3. Quantitative and Qualitative Disclosures About Market Risk. | 25
Item 4. Controls and Procedures. | 25
PART II - OTHER INFORMATION | 27
Item 1. Legal Proceedings. | 27
Item 1A. Risk Factors. | 27
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. | 27
Item 3. Defaults upon Senior Securities. | 28
Item 4. Mine Safety Disclosures. | 28
Item 5. Other Information. | 28
Item 6. Exhibits. | 28
PART III | ​
SIGNATURE | 29

​

​

​

2

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

PRIVETERRA ACQUISITION CORP.

CONDENSED BALANCE SHEETS

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, |  | December 31,
​ | ​ | 2022 | ​ | 2021
​ | ​ | (unaudited) | ​ | ​
Assets | ​ | ​ | ​ | ​ | ​ | ​
Current assets | ​ | ​ | ​ | ​ | ​ | ​
Cash | ​ | $ | 27,759 | ​ | $ | 497,412
Prepaid assets | ​ |  | 138,412 | ​ |  | 337,812
Total Current Assets | ​ | ​ | 166,171 | ​ | ​ | 835,224
​ | ​ | ​ | ​ | ​ | ​ | ​
Prepaid assets – non-current | ​ |  | — | ​ |  | 34,619
Investments held in Trust Account | ​ | ​ | 277,156,370 | ​ | ​ | 276,079,687
Total Assets | ​ | $ | 277,322,541 | ​ | $ | 276,949,530
​ | ​ | ​ | ​ | ​ | ​ | ​
Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Deficit | ​ |  | ​ | ​ |  | ​
Current liabilities: | ​ | ​ | ​ | ​ | ​ | ​
Accounts payable and accrued expenses | ​ | $ | 943,789 | ​ | $ | 634,585
Franchise tax payable | ​ | ​ | 150,000 | ​ | ​ | 200,000
Income tax payable | ​ | ​ | 254,238 | ​ | ​ | —
Total current liabilities | ​ | ​ | 1,348,027 | ​ | ​ | 834,585
​ | ​ | ​ | ​ | ​ | ​ | ​
Warrant liabilities | ​ |  | 961,413 | ​ |  | 7,384,800
Deferred underwriters’ discount | ​ |  | 9,660,000 | ​ |  | 9,660,000
Total liabilities | ​ |  | 11,969,440 | ​ |  | 17,879,385
​ | ​ |  | ​ | ​ |  |
Commitments and Contingencies | ​ |  | ​ | ​ |  |
​ | ​ | ​ | ​ | ​ | ​ | ​
Class A common stock subject to possible redemption, 27,600,000 shares as of September 30, 2022 and December 31, 2021, at redemption value of $10.03 and $10.00, respectively | ​ | ​ | 276,904,815 | ​ | ​ | 276,000,000
​ | ​ |  | ​ | ​ |  |
Stockholders’ Deficit: | ​ |  | ​ | ​ |  |
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | ​ |  | — | ​ |  | —
Class A common stock, $0.0001 par value; 280,000,000 shares authorized; 0 shares issued and outstanding (excluding 27,600,000 shares subject to possible redemption) as of September 30, 2022 and December 31, 2021, respectively | ​ |  | — | ​ |  | —
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 6,900,000 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively | ​ |  | 690 | ​ |  | 690
Additional paid-in capital | ​ |  | 32,000 | ​ |  | 32,000
Accumulated deficit | ​ | ​ | (11,584,404) | ​ | ​ | (16,962,545)
Total Stockholders’ Deficit | ​ |  | (11,551,714) | ​ |  | (16,929,855)
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Deficit | ​ | $ | 277,322,541 | ​ | $ | 276,949,530

​

The accompanying notes are an integral part of the unaudited condensed financial statements.

​

3

Table of Contents

PRIVETERRA ACQUISITION CORP.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended | ​ | For the Nine Months Ended
​ | ​ | September 30, | ​ | September 30,
​ |  | 2022 |  | 2021 |  | 2022 |  | 2021
Formation and operating costs | ​ | $ | 488,099 | ​ | $ | 450,892 | ​ | $ | 1,304,376 | ​ | $ | 1,050,199
Loss from operations | ​ | ​ | (488,099) | ​ | ​ | (450,892) | ​ | ​ | (1,304,376) | ​ | ​ | (1,050,199)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Other income (expense) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Unrealized loss on change in fair value of warrants | ​ | ​ | 1,216,614 | ​ | ​ | 6,088,400 | ​ | ​ | 6,423,387 | ​ | ​ | 9,599,733
Offering costs allocated to warrant liabilities | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (655,046)
Interest earned on investments held in Trust Account | ​ | ​ | 1,151,217 | ​ | ​ | 21,434 | ​ | ​ | 1,418,183 | ​ | ​ | 58,469
Total other income (expense), net | ​ | ​ | 2,367,831 | ​ | ​ | 6,109,834 | ​ | ​ | 7,841,570 | ​ | ​ | 9,003,156
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income before provision for income taxes | ​ | ​ | 1,879,732 | ​ | ​ | 5,658,942 | ​ | ​ | 6,537,194 | ​ | ​ | 7,952,957
Provision for income taxes | ​ | ​ | (237,273) | ​ | ​ | — | ​ | ​ | (254,238) | ​ | ​ | —
Net income | ​ | $ | 1,642,459 | ​ | $ | 5,658,942 | ​ | $ | 6,282,956 | ​ | $ | 7,952,957
​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
Basic and diluted weighted average shares outstanding, Class A common stock | ​ |  | 27,600,000 | ​ |  | 27,600,000 | ​ |  | 27,600,000 | ​ | ​ | 23,454,945
Basic and diluted net income per share, Class A common stock | ​ | $ | 0.05 | ​ | $ | 0.16 | ​ | $ | 0.18 | ​ | $ | 0.26
Basic and diluted weighted average shares outstanding, Class B common stock | ​ |  | 6,900,000 | ​ |  | 6,900,000 | ​ |  | 6,900,000 | ​ |  | 6,900,000
Basic and diluted net income per share, Class B common stock | ​ | $ | 0.05 | ​ | $ | 0.16 | ​ | $ | 0.18 | ​ | $ | 0.26

​

The accompanying notes are an integral part of the unaudited condensed financial statements.

​

4

Table of Contents

PRIVETERRA ACQUISITION CORP.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(Unaudited)

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Common Stock | ​ | Additional | ​ | ​ | ​ | ​ | Total
​ | ​ | Class A | ​ | Class B | ​ | Paid-in | ​ | Accumulated | ​ | Stockholders’
​ |  | Shares |  | Amount |  | Shares |  | Amount |  | Capital |  | Deficit |  | Deficit
Balance — January 1, 2022 | ​ | — | ​ | $ | — | ​ | 6,900,000 | ​ | $ | 690 | ​ | $ | 32,000 | ​ | $ | (16,962,545) | ​ | $ | (16,929,855)
Net income |  | — | ​ |  | — | ​ | — | ​ | ​ | — | ​ |  | — | ​ |  | 2,773,393 | ​ |  | 2,773,393
Balance — March 31, 2022 (unaudited) |  | — | ​ | ​ | — | ​ | 6,900,000 | ​ | ​ | 690 | ​ | ​ | 32,000 | ​ | ​ | (14,189,152) | ​ | ​ | (14,156,462)
Accretion of Class A common stock to redemption value | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (79,687) | ​ | ​ | (79,687)
Net income | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 1,867,104 | ​ | ​ | 1,867,104
Balance — June 30, 2022 (unaudited) | ​ | — | ​ | ​ | — | ​ | 6,900,000 | ​ | ​ | 690 | ​ | ​ | 32,000 | ​ | ​ | (12,401,735) | ​ | ​ | (12,369,045)
Accretion of Class A common stock to redemption value | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (825,128) | ​ | ​ | (825,128)
Net income | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 1,642,459 | ​ | ​ | 1,642,459
Balance as of September 30, 2022 (unaudited) | ​ | — | ​ | $ | — | ​ | 6,900,000 | ​ | $ | 690 | ​ | $ | 32,000 | ​ | $ | (11,584,404) | ​ | $ | (11,551,714)

​

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Common Stock | ​ | Additional | ​ | ​ | ​ | ​ | Total
​ | ​ | Class A | ​ | Class B | ​ | Paid-In | ​ | Accumulated | ​ | Stockholders’
​ |  | Shares |  | Amount |  | Shares |  | Amount |  | Capital |  | Deficit |  | Equity (Deficit)
Balance—December 31, 2020 | ​ | — | ​ | $ | — | ​ | 6,900,000 | ​ | $ | 690 | ​ | $ | 24,310 | ​ | $ | (3,588) | ​ | $ | 21,412
Excess cash over fair value for Private Placement Warrants | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | 1,199,067 | ​ | ​ | — | ​ | ​ | 1,199,067
Accretion of Class A common stock to redemption value | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | (1,223,377) | ​ | ​ | (25,159,789) | ​ | ​ | (26,383,166)
Net income |  | — | ​ |  | — | ​ | — | ​ | ​ | — | ​ |  | — | ​ |  | 6,319,210 | ​ |  | 6,319,210
Balance as of March 31, 2021 (unaudited) |  | — | ​ | ​ | — | ​ | 6,900,000 | ​ | ​ | 690 | ​ | ​ | — | ​ | ​ | (18,844,167) | ​ | ​ | (18,843,477)
Proceeds received in excess of fair value for Working Capital Loan conversion into Private Placement Warrants | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | 32,000 | ​ | ​ | — | ​ | ​ | 32,000
Net loss | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (4,025,194) | ​ | ​ | (4,025,194)
Balance as of June 30, 2021 (unaudited) | ​ | — | ​ | ​ | — | ​ | 6,900,000 | ​ | ​ | 690 | ​ | ​ | 32,000 | ​ | ​ | (22,869,361) | ​ | ​ | (22,836,671)
Net income | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 5,658,942 | ​ | ​ | 5,658,942
Balance as of September 30, 2021 (unaudited) | ​ | — | ​ | $ | — | ​ | 6,900,000 | ​ | $ | 690 | ​ | $ | 32,000 | ​ | $ | (17,210,419) | ​ | $ | (17,177,729)

​

The accompanying notes are an integral part of the unaudited condensed financial statements.

​

5

Table of Contents

PRIVETERRA ACQUISITION CORP.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

​

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | For the Nine |  | For the Nine
​ | ​ | Months Ended | ​ | Months Ended
​ | ​ | September 30, | ​ | September 30,
​ | ​ | 2022 | ​ | 2021
Cash Flows from Operating Activities: | ​ | ​ | ​ | ​ | ​ | ​
Net income | ​ | $ | 6,282,956 | ​ | $ | 7,952,957
Adjustments to reconcile net income to net cash used in operating activities: | ​ |  | ​ | ​ |  | ​
Interest earned on investments held in Trust Account | ​ | ​ | (1,418,183) | ​ | ​ | (58,469)
Unrealized loss on change in fair value of warrants | ​ | ​ | (6,423,387) | ​ | ​ | (9,599,733)
Offering costs allocated to warrant liabilities | ​ | ​ | — | ​ | ​ | 655,046
Changes in operating assets and liabilities: | ​ |  |  | ​ |  |
Prepaid assets | ​ | ​ | 234,019 | ​ | ​ | (480,956)
Franchise and income tax payable | ​ | ​ | 204,238 | ​ | ​ | 150,000
Accrued expenses | ​ | ​ | 309,204 | ​ | ​ | 49,000
Net cash used in operating activities | ​ |  | (811,153) | ​ |  | (1,332,155)
​ | ​ | ​ | ​ | ​ | ​ | ​
Cash Flows from Investing Activities: | ​ | ​ | ​ | ​ | ​ | ​
Principal invested into Trust account | ​ | ​ | — | ​ | ​ | (276,000,000)
Withdrawal from Trust Account for tax obligations | ​ | ​ | 341,500 | ​ | ​ | —
Net cash provided by (used in) investing activities | ​ | ​ | 341,500 | ​ | ​ | (276,000,000)
​ | ​ | ​ | ​ | ​ | ​ | ​
Cash Flows from Financing Activities: | ​ |  |  | ​ |  |
Due to related party | ​ | ​ | — | ​ | ​ | 3,495
Proceeds from sale of Units, net of underwriter fee | ​ |  | — | ​ |  | 270,480,000
Payment of offering costs | ​ | ​ | — | ​ | ​ | (369,212)
Proceeds from issuance of Private Placement Warrants | ​ | ​ | — | ​ | ​ | 7,920,000
Borrowing from promissory note | ​ |  | — | ​ |  | 35,192
Repayment of promissory note | ​ |  | — | ​ |  | (73,780)
Net cash provided by financing activities | ​ |  | — | ​ |  | 277,995,695
Net Change in Cash | ​ |  | (469,653) | ​ |  | 663,540
Cash - Beginning of period | ​ |  | 497,412 | ​ |  | —
Cash - End of period | ​ | $ | 27,759 | ​ | $ | 663,540
​ | ​ | ​ | ​ | ​ | ​ | ​
Supplemental Disclosure of Non-cash Financing Activities: | ​ |  | ​ | ​ |  | ​
Deferred underwriters’ discount payable charged to additional paid in capital | ​ | $ | — | ​ | $ | 9,660,000
Conversion of Working Capital Loans to Private Placement Warrants | ​ | $ | — | ​ | $ | 100,000

​

The accompanying notes are an integral part of the unaudited condensed financial statements.

​

​

​

6

Table of Contents

PRIVETERRA ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

Note 1 — Organization and Business Operation

Organization and General

Priveterra Acquisition Corp. (the “Company”) is a blank check company incorporated in Delaware on November 17, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (“Business Combination”).

The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of September 30, 2022, the Company had not commenced any operations. All activity for the period from November 17, 2020, the Company’s inception, through September 30, 2022, relates to the Company’s formation and the initial public offering (“IPO”), described below, and identifying a target company for a business combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the IPO and unrealized gains and losses on the change in fair value of it warrants. The Company has selected December 31 as its fiscal year end.

The Company’s sponsor is Priveterra Sponsor, LLC, a Delaware limited liability company (the “Sponsor”).

Financing

The registration statement for the Company’s IPO was declared effective on February 8, 2021 (the “Effective Date”). On February 11, 2021, the Company consummated an IPO of 27,600,000 units at $10.00 per unit (the “Units”), which includes the full exercise by the underwriters of the over-allotment option to purchase an additional 3,600,000 Units, at $10.00 per Unit, generating gross proceeds of $276,000,000, which is discussed in Note 3.

Simultaneously with the closing of the IPO, the Company consummated the sale of 5,213,333 warrants (the “Private Placement Warrants”), at a price of $1.50 per warrant, which is discussed in Note 4. Each warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, generating gross proceeds of $7,820,000.

Transaction costs of the IPO amounted to $15,630,212 consisting of $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees, and $450,212 of other offering costs. Of the transaction costs, $655,046 is included in offering costs on the statements of operations and $14,975,165 is included in equity.

7

Table of Contents

Trust Account

Following the closing of the IPO on February 11, 2021, $276,000,000 ($10.00 per Unit) from the net offering proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), located in the United States with Continental Stock Transfer & Trust Company acting as trustee and will be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (“Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its franchise and income tax obligations, if any, the proceeds from the Company’s IPO and the sale of the Private Placement Warrants will not be released from the Trust Account until the earliest of (i) the completion of initial Business Combination, (ii) the redemption of the Company’s public shares if the Company does not complete an initial Business Combination within 24 months from the closing of the IPO, subject to applicable law, or (iii) the redemption of the Company’s public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if the Company has not consummated an initial business combination within 24 months from the closing of the IPO or with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholders.

Initial Business Combination

The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a stockholder meeting called to approve the initial Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their shares for a pro rata portion of the amount then on deposit in the Trust Account (initially approximately $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations).

The shares of common stock subject to redemption are recorded at a redemption value and classified as temporary equity upon the IPO, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.

The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to their founder shares and public shares in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their founder shares and public shares in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation, and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder shares if the Company fails to complete the initial Business Combination within the Combination Period.

Liquidation

The Company will have 24 months from the closing of the IPO to complete the initial Business Combination (the “Combination Period”). However, if the Company is unable to complete the initial Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, liquidate and dissolve, subject, in each case, to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

8

Table of Contents

The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.10 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Company’s IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Company’s Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations.

Liquidity, Capital Resources and Going Concern

The Company’s liquidity needs up to February 11, 2021, the date of the IPO, had been satisfied through a capital contribution from the Sponsor of $25,000 (see Note 5) for the founder shares and the loans under an unsecured promissory note from the Sponsor of $73,295 (see Note 5). In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 5).

The Company’s IPO was on February 11, 2021. As of September 30, 2022, the Company had $27,759 in its operating bank account, and working capital deficit of $930,301 (excluding taxes payable which is funded by earnings from the Trust Account) and has incurred and expects to incur additional significant costs in pursuit of its financing and acquisition plans.

Additionally, the Company has until February 11, 2023 to consummate a Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements– Going Concern,” Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. The Company intends to complete a Business Combination before the mandatory liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities

​

​

​

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Form 10-K for the year ended December 31, 2021 as filed with the SEC on March 25, 2022, which contains the audited financial statements and notes thereto. The interim results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future interim periods.

9

Table of Contents

Emerging Growth Company Status

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had approximately $28,000 and $497,000 in cash and did not have any cash equivalents as of September 30, 2022 and December 31, 2021.

Investments Held in Trust Account

The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying condensed balance sheets and adjusted for the amortization or accretion of premiums or discounts.

10

Table of Contents

Offering Costs associated with the Initial Public Offering

The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering. Offering costs are charged to temporary equity or the statement of operations based on the relative value of the Public Warrants to the proceeds received from the Units sold upon the completion of the IPO. Accordingly, as of September 30, 2022, offering costs totaling $15,630,212 (consisting of $5,220,000 of underwriting discount, $9,660,000 of deferred underwriting discount, and $450,212 of other offering costs) were recognized with $ 655,046 which was allocated to the Public Warrants and Private Warrants, included in the statement of operations and $14,975,166 included in temporary equity.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Class A Common Stock Subject to Possible Redemption

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that is considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets.

As of September 30, 2022 and December 31, 2021, the common stock subject to possible redemption reflected on the condensed balance sheets are reconciled in the following table:

​

​ | ​ | ​ | ​
Gross proceeds from IPO |  | $ | 276,000,000
Less: | ​ | ​ | ​
Proceeds allocated to Public Warrants | ​ |  | (11,408,000)
Class A common stock issuance costs | ​ |  | (14,975,165)
Plus: | ​ | ​ | ​
Accretion of carrying value to redemption value | ​ |  | 26,383,165
Class A common stock subject to possible redemption, December 31, 2021 | ​ | ​ | 276,000,000
Plus: | ​ | ​ | ​
Accretion of carrying value to redemption value | ​ | ​ | 904,815
Class A common stock subject to possible redemption, September 30, 2022 | ​ | $ | 276,904,815

​

Net Income Per Common Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income per common share is computed by dividing net income by the weighted average number of common stock outstanding for the period. The Company has two classes of common shares, which are referred to as Class A common stock and Class B common stock. Earnings and losses are shared pro rata between the two classes of stock. Private and public warrants to purchase 14,480,000 Class A common stock at $11.50 per share were issued on February 8, 2021. No warrants were exercised during the three and nine months ended September 30, 2022 and 2021. The calculation of diluted income per common share does not consider the effect of the warrants issued in connection with the (i) IPO, (ii) exercise of over-allotment, and (iii) Private Placement since the exercise of the warrants are contingent upon the occurrence of future events. As of September 30, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company As a result, diluted net income per common share is the same as basic net income per common share for the periods. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.

11

Table of Contents

Below is a reconciliation of the net income per share of common stock:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended | ​ | For the Nine Months Ended
​ | ​ | September 30, 2022 | ​ | September 30, 2022
​ |  | Class A |  | Class B |  | Class A |  | Class B
Basic and diluted net income per common share |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Numerator: |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Allocation of net income | ​ | $ | 1,313,967 | ​ | $ | 328,492 | ​ | $ | 5,026,365 | ​ | $ | 1,256,591
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Denominator | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Weighted-average shares outstanding | ​ |  | 27,600,000 | ​ |  | 6,900,000 | ​ |  | 27,600,000 | ​ |  | 6,900,000
Basic and diluted net income per common share | ​ | $ | 0.05 | ​ | $ | 0.05 | ​ | $ | 0.18 | ​ | $ | 0.18

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended | ​ | For the Nine Months Ended
​ | ​ | September 30, | ​ | September 30,
​ |  | 2021 |  | 2021
​ |  | Class A |  | Class B |  | Class A |  | Class B
Basic and diluted net income per common share: |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​
Numerator: |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​
Allocation of net income |  | $ | 4,527,154 | ​ | $ | 1,131,788 |  | $ | 6,123,777 | ​ | $ | 1,829,180
​ |  |  | ​ | ​ |  | ​ |  |  | ​ | ​ |  | ​
Denominator: |  |  | ​ | ​ |  | ​ |  |  | ​ | ​ |  | ​
Weighted-average shares outstanding |  |  | 27,600,000 | ​ |  | 6,900,000 |  |  | 23,454,945 | ​ |  | 6,900,000
Basic and diluted net income per common share |  | $ | 0.16 | ​ | $ | 0.16 |  | $ | 0.26 | ​ | $ | 0.26

​

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the condensed balance sheets, primarily due to its short-term nature, other than the derivative warrant liability.

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the condensed statements of operations. Derivative assets and liabilities are classified in the condensed balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the condensed balance sheet date. The Company has determined the warrants are a derivative instrument.

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:

| ● | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

| ● | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

| ● | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

12

Table of Contents

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2022 and December 31, 2021, the Company’s deferred tax asset had a full valuation allowance recorded against it. The Company’s tax rate was 12.62% and 0.00% for the three months ended September 30, 2022 and 2021, respectively, and 3.89% and 0.00% for the nine months ended September 30, 2022 and 2021, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2022 and 2021, due to changes in the valuation allowance on the deferred tax assets.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these condensed financial statements.

Inflation Reduction Act of 2022

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

13

Table of Contents

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.

Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. ASU 2016-13 also requires additional disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. The Company expects to adopt the provisions of this guidance on January 1, 2023. The adoption is not expected to have a material impact on the Company’s condensed financial statements.

Besides the above, the Company’s management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted. would have a material effect on the accompanying condensed financial statements.

​

​

​

NOTE 3. INITIAL PUBLIC OFFERING

On February 11, 2021, the Company sold 27,600,000 Units, at a purchase price of $ 10.00 per Unit, which includes the full exercise by the underwriters of their option to purchase an additional 3,600,000 Units at $10.00 per Unit. Each Unit was sold at $10.00 and consisted of one share of Class A common stock, and one-third warrant to purchase one share of Class A common stock (“Public Warrant”). Each whole Public Warrant entitles the holder thereof to purchase one share of common stock at a price of $11.50 per share, subject to adjustment. Each warrant will become exercisable on the later of 30 days after the completion of the initial Business Combination or 12 months after the closing of the Company’s IPO on February 11, 2021 and will expire five years after the completion of the initial Business Combination, or earlier upon redemption or liquidation. (see Note 4).

The Company paid underwriting fees at the closing of the IPO of $5,520,000. As of February 11, 2021 an additional fee of $9,660,000 (see Note 6) was deferred and will become payable upon the Company’s completion of an initial Business Combination. The deferred portion of the fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes its initial Business Combination.

Warrants — Each whole warrant entitles the holder to purchase one Class A common stock at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any founder shares held by the initial stockholders or such affiliates, as applicable, prior to such issuance), (the “Newly Issued Price”) (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described under “— Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

14

Table of Contents

The warrants will become exercisable on the later of 12 months from the closing of the IPO or 30 days after the completion of its initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

The Company has agreed that as soon as practicable, but in no event later than fifteen (15) business days after the closing of the initial Business Combination, it will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Once the warrants become exercisable, the Company may call the warrants for redemption for cash:

| ● | in whole and not in part;

| ● | at a price of $0.01 per warrant;

| ● | upon not less than 30 days’ prior written notice of redemption to each warrant holder (the “30-day redemption period”)

| ● | if, and only if, the closing price of the common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like and for certain issuances of Class A common stock and equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination as described elsewhere in the IPO) for any 20 trading days within a 30-trading day period ending three business days before the Company sends to the notice of redemption to the warrant holders; and

| ● | if the last sale price of the Class A common stock is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like), the Private Placement Warrants must also be concurrently called for redemption on the same terms (except as described above with respect to a holder’s ability to cashless exercise its warrants) as the outstanding public warrants, as described above.

​

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 5,213,333 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $7,820,000.

Each Private Placement Warrant was identical to the Public Warrants sold in the IPO, except that the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the Company’s initial Business Combination, and (iii) may be exercised by the holders on a cashless basis. The Company’s Sponsor has agreed to (i) waive its redemption rights with respect to its founder shares and public shares in connection with the completion of the Company’s initial Business Combination, (ii) waive its redemption rights with respect to its founder shares and public shares in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if the Company does not complete its initial Business Combination within 18 months (or up to 24 months if the Company extends the period of time) from the closing of the Company’s IPO on February 11, 2021 or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity and (iii) waive its rights to liquidating distributions from the Trust Account with respect to its founder shares if the Company fails to complete its initial Business Combination within 18 months (or up to 24 months if the Company extends the period of time) from the closing of the Company’s IPO on February 11, 2021. In addition, the Company’s Sponsor has agreed to vote any founder shares held by them and any public shares purchased during or after the Company’s IPO (including in open market and privately negotiated transactions) in favor of the Company’s initial Business Combination.

15

Table of Contents

​

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

On December 17, 2020, the Sponsor paid $25,000, or approximately $0.004 per share, to cover certain offering costs in consideration for 5,750,000 Class B common stock, par value $0.0001 (the “Founder Shares). On February 8, 2021, as part of an upsizing of the IPO, the Company effected a stock split in which each issued share of Class B Common Stock that was outstanding was converted into one and two tenths shares of Class B common stock, resulting in an aggregate of 6,900,000 shares of Class B common stock issued and outstanding. All shares and associated amounts have been retroactively restated to reflect the surrender of these shares. The founder shares included an aggregate of up to 900,000 shares subject to forfeiture if the over-allotment option was not exercised by the underwriters in full. As a result of the underwriters’ election to fully exercise of their over-allotment option, the 900,000 shares were no longer subject to forfeiture.

The initial stockholders have agreed not to transfer, assign or sell any of their Founder Shares and any Class A common stock issuable upon conversion thereof until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) the date following the completion of the initial Business Combination on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of its stockholders having the right to exchange their common stock for cash, securities or other property (the “lock-up”). Notwithstanding the foregoing, if the closing price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 180 days after the initial Business Combination, the founder shares will be released from the lockup.

Promissory Note – Related Party

On December 17, 2020, the Sponsor agreed to loan the Company up to $75,000 to be used for a portion of the expenses of the IPO. On January 13, 2021, the Sponsor agreed to loan the Company up to an additional $50,000 to be used for a portion of the expenses of the IPO. These loans are non-interest bearing, unsecured and were due at the earlier of June 30, 2021 or the closing of the IPO. The loan was repaid upon the closing of the IPO out of the offering proceeds. As of September 30, 2022 and December 31, 2021, the Company had no amounts outstanding borrowings under the promissory note. Additionally, this note is no longer available to the Company.

Working Capital Loans

The Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes the initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into Private Placement Warrants at a price of $1.50 per warrant at the option of the lender (the “Working Capital Warrants”). Such warrants would be identical to the Private Placement Warrants. In June 2021 the Company had $100,000 of Working Capital Loans outstanding which were converted into 66,667 Working Capital Warrants. As of September 30, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans.

Administrative Service Fee

The Company has agreed, commencing on February 8, 2021, to pay $25,000 per month for administrative and other services, of which $10,000 per month will be paid to the Sponsor for office space and administrative services provided to members of the management team and up to $15,000 will be used to compensate the Company’s Chief Operating Officer and Chief Financial Officer and Secretary for a portion of their time spent on the Company’s affairs. Upon completion of the Company’s Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the three and nine months ended September 30, 2022, $75,000 and $225,000 was recognized in the condensed statements of operations and has been paid. For the three and nine months ended September 30, 2021, $191,964 was recognized in the condensed statements of operations and has been paid.

​

16

Table of Contents

NOTE 6. COMMITMENTS AND CONTINGENCIES

Underwriters Agreement

The underwriters are entitled to a deferred fee of $0.35 per Unit, or $9,660,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Registration Rights

The holders of the founder shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them pursuant to a registration rights agreement to be signed in connection with the Company’s IPO. These holders will be entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities for sale under the Securities Act. In addition, these holders will have “piggy-back” registration rights to include their securities in other registration statements filed by the Company.

​

NOTE 7. STOCKHOLDERS’ DEFICIT

Preferred Stock — The Company is authorized to issue a total of 1,000,000 preferred shares at par value of $0.0001 each. At September 30, 2022 and December 31, 2021, there were no shares of preferred stock issued or outstanding.

Class A Common Stock—The Company is authorized to issue 280,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of September 30, 2022 and December 31, 2021, there were no shares of Class A common stock issued or outstanding (excluding 27,600,000 shares subject to redemption), respectively.

Class B Common Stock — The Company is authorized to issue 20,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders are entitled to one vote for each share of Class B common stock. At September 30, 2022 and December 31, 2021, there were 6,900,000 shares of Class B common stock issued and outstanding.

Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders except as required by law. Unless specified in the Company’s amended and restated certificate of incorporation, or as required by applicable provisions of the Delaware state law or applicable stock exchange rules, the affirmative vote of a majority of the Company’s shares of common stock that are voted is required to approve any such matter voted on by its stockholders.

The Class B common stock will automatically convert into Class A common stock concurrently with or immediately following the consummation of the initial Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of Class A common stock outstanding after such conversion (after giving effect to any redemptions of Class A common stock by public stockholders), including the total number of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A common stock or equity-linked securities exercisable for or convertible into Class A common stock issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of founder shares will never occur on a less than one-for-one basis.

​

NOTE 8. RECURRING FAIR VALUE MEASUREMENTS

At September 30, 2022 and December 31, 2021, the Company’s warrant liability was valued at $961,413 and $7,384,800, respectively. Under the guidance in ASC 815-40 the Warrants do not meet the criteria for equity treatment. As such, the Warrants must be recorded on the condensed balance sheet at fair value. This valuation is subject to re-measurement at each balance sheet date. With each re-measurement, the warrant valuation will be adjusted to fair value, with the change in fair value recognized in the Company’s condensed statement of operations.

17

Table of Contents

The Company’s warrant liability for the Private Placement Warrants is based on a valuation model utilizing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. The fair value of the Private Warrant liability classified within Level 3 of the fair value hierarchy.

The Company’s warrant liability for the Public Warrants is based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. The fair value of the Public Warrant liability is classified within Level 1 of the fair value hierarchy.

The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying condensed balance sheets and adjusted for the amortization or accretion of premiums or discounts.

At September 30, 2022, assets held in the Trust Account were comprised of $17,591 in cash and should be $277,138,779 only then if you add $17,591 will this tie back to the Balance sheet balance of 277,156,370 in U.S. Treasury Bills. During the three and nine months ended September 30, 2022, the Company withdrew $341,500 in interest income from the Trust Account for tax obligation purposes.

At December 31, 2021, assets held in the Trust Account were comprised of $52 in cash and should be $276,079,635 only then if you add $52 will this tie back to the Balance sheet balance of 276,079,687 in U.S. Treasury Bills. During the year ended December 31, 2021, the Company did not withdraw interest income from the Trust Account.

The following table presents information about the Company’s gross holding gains and fair value of held-to-maturity securities at September 30, 2022 and December 31, 2021:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ |  | ​ | ​ |  | Gross |  | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | Amortized | ​ | Holding | ​ | ​ | ​
​ | ​ | Held-To-Maturity | ​ | Level | ​ | Cost | ​ | Gain | ​ | Fair Value
September 30, 2022 |  | U.S. Treasury Bill (Matures on 10/06/2022) |  | 1 | ​ | $ | 277,138,779 | ​ | $ | 9,566 | ​ | $ | 277,148,345
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
December 31, 2021 |  | U.S. Treasury Bill (Matures on 01/06/2022) |  | 1 | ​ | $ | 276,079,635 | ​ | $ | 1,273 | ​ | $ | 276,080,908

​

The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of September 30, 2022 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Level 1 |  | Level 2 |  | Level 3
Liabilities: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Private Placement Warrants |  | $ | — |  | $ | — |  | $ | 356,053
Public Warrants |  | $ | — |  | $ | 605,360 |  | $ | —

​

18

Table of Contents

The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of December 31, 2021 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Level 1 |  | Level 2 |  | Level 3
Liabilities: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Private Placement Warrants | ​ | $ | — | ​ | $ | — | ​ | $ | 2,692,800
Public Warrants | ​ | $ | 4,692,000 | ​ | $ | — | ​ | $ | —

​

Measurement

The Company established the initial fair value for the Warrants on February 11, 2021, the date of the consummation of the Company’s IPO using a Monte Carlo simulation model to value the Public Warrants and a modified Black-Scholes model to value the Private Placement Warrants. The Warrants were initially classified within Level 3 of the fair value hierarchy due to the use of unobservable inputs. In April 2021, the Public Warrants began trading in the open market and were reclassified to Level 1. On September 30, 2022 and December 31, 2021, the fair value was remeasured. At September 30, 2022 and December 31, 2021, the Company used a Monte Carlo simulation and modified Black-Scholes model, respectively, to value the Private Placement Warrants. The Private Placement Warrants were classified within Level 3 of the fair value hierarchy at the measurement date due to the use of unobservable inputs. The Company’s Private Placement Warrant liability is based on a valuation model utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. Significant deviations from these estimates and inputs could result in a material change in fair value.

The key inputs into the valuation models was as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, | ​ | September 30, | ​
Input |  | 2021 |  | 2022 |
Risk-free interest rate | ​ | ​ | 1.26 | % | ​ | 4.04 | %
Expected term (years) | ​ | ​ | 5.0 | ​ | ​ | 5.39 | ​
Expected volatility | ​ | ​ | 10.50 | % | ​ | 6.9 | %
Dividend rate | ​ | ​ | 0.0 | % | ​ | 0.0 | %
Exercise price | ​ | $ | 11.50 | ​ | $ | 11.50 | ​
Market implied likelihood of IBC | ​ | ​ | — | % | ​ | 6.9 | %

​

The following table provides a reconciliation of changes in fair value of the beginning and ending balances for the Company’s assets and liabilities classified as level 3 for the three and nine months ended September 30, 2022 and September 30, 2021.

​ | ​ | ​ | ​
Fair Value at December 31, 2021 | ​ | $ | 2,692,800
Change in fair value | ​ |  | (1,100,880)
Fair Value at March 31, 2022 | ​ | ​ | 1,591,920
Change in fair value | ​ | ​ | (793,893)
Fair Value at June 30, 2022 | ​ | ​ | 798,027
Change in fair value | ​ | ​ | (441,974)
Fair Value at September 30, 2022 | ​ | $ | 356,053

​

​

19

Table of Contents

​

​ | ​ | ​ | ​
Fair Value at issuance February 11, 2021 |  | $ | 18,028,933
Change in fair value | ​ |  | (7,166,800)
Fair Value at March 31, 2021 | ​ | ​ | 10,862,133
Public Warrants reclassified to level 2 | ​ | ​ | (9,200,000)
Issuance of Private Placement Warrants upon conversion of Working Capital Loans | ​ | ​ | 68,000
Change in fair value | ​ | ​ | 3,655,467
Fair Value at June 30, 2021 | ​ | ​ | 5,385,600
Change in fair value | ​ | ​ | (2,270,400)
Fair Value at September 30, 2021 | ​ | $ | 3,115,200

​

​

​

NOTE 9. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any additional subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

​

​

20

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References to the “Company,” “Priveterra Acquisition Corp.,” “our,” “us” or “we” refer to Priveterra Acquisition Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.

Overview

We are a blank check company incorporated in Delaware on November 17, 2020. We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).

Our Sponsor is Priveterra Sponsor, LLC, a Delaware limited liability company. The registration statement for the Initial Public Offering was declared effective on February 8, 2021. On February 11, 2021, we consummated the Initial Public Offering of 27,600,000 Units, at $10.00 per Unit, generating gross proceeds of $276,000,000, and incurring offering costs of approximately $5,520,000, inclusive of approximately $9,660,000 in deferred underwriting commissions.

Simultaneously with the closing of the Initial Public Offering, we consummated the Private Placement of 5,213,333 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant to our Sponsor, generating gross proceeds to us of approximately $7,820,000.

Upon the closing of the Initial Public Offering and the Private Placement, $276,000,000 ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in the Trust Account and was invested in permitted United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act that invest only in direct U.S. government treasury obligations.

Our management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.

​

21

Table of Contents

We will only have 24 months from the closing of the Initial Public Offering, or February 11, 2023, to complete our initial Business Combination (the “Combination Period”). If we do not complete a Business Combination within this period of time, we will (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares for a per share pro rata portion of the Trust Account, including interest and not previously released to us to fund our working capital requirements (less taxes payable and up to $100,000 of such net interest to pay dissolution expenses) and (iii) as promptly as possible following such redemption, dissolve and liquidate the balance of our net assets to our remaining stockholders, as part of our plan of dissolution and liquidation. Our Sponsor and our executive officers and independent director nominees (the “initial stockholders”) entered into a letter agreement with us, pursuant to which they have waived their rights to participate in any redemption with respect to their Founder Shares; however, if the initial stockholders or any of our officers, directors or affiliates acquire shares of common stock in or after the Initial Public Offering, they will be entitled to a pro rata share of the Trust Account upon our redemption or liquidation in the event we do not complete a Business Combination within the required time period. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the Initial Public Offering price per Unit in the Initial Public Offering.

Liquidity and Capital Resources

As of September 30, 2022, we had $27,759 in our operating bank account and working capital deficit of $930,301 (excluding taxes payable which is funded by earnings from the Trust Account).

Prior to the completion of the Initial Public Offering, our liquidity needs have been satisfied through a capital contribution from the Sponsor of $25,000 for the founder shares and loans under an unsecured promissory note from the Sponsor of $73,295. On February 15, 2021, we issued an unsecured convertible promissory note to our Sponsor, pursuant to which we may borrow up to $1,500,000 from our sponsor for ongoing expenses reasonably related to our business and the consummation of an initial business combination. All unpaid principal under the convertible note will be due and payable in full on the earlier of (i) February 11, 2023 and (ii) the effective date of our initial business combination. Our Sponsor will have the option, at any time on or prior to such maturity date, to convert any amounts outstanding under the convertible note into warrants to purchase shares of our Class A common stock, par value $0.0001 per share, at a conversion price of $1.50 per warrant, with each warrant entitling the holder to purchase one share of our Class A common stock at a price of $11.50 per share, subject to the same adjustments applicable to the private placement warrants sold concurrently with our initial public offering. In June 2021 we had $100,000 of Working Capital Loans outstanding which were converted into 66,667 Working Capital Warrants. As of September 30, 2022 and December 31, 2021, there were no borrowings under the Working Capital Loans.

We have approximately $28,000 in cash and approximately $1,300,000 in current liabilities as of September 30, 2022 and have incurred and expects to incur additional significant costs in pursuit of financing and acquisition plans. Additionally, we have until February 11, 2023 to consummate a Business Combination. In connection with our assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements– Going Concern,” we have determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about our ability to continue as a going concern. We intend to complete a Business Combination before the mandatory liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after February 11, 2023.

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the balance sheets. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Results of Operations

Our entire activity since inception through September 30, 2022 related to our formation, the preparation for the Initial Public Offering, and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. We have neither engaged in any operations nor generated any revenues to date. We will not generate any operating revenues until after completion of our initial Business Combination. We will generate non-operating income in the form of interest income and dividends on investments held in Trust Account. Additionally, we will recognize unrealized gains or loss related to our Warrants. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

22

Table of Contents

For the three months ended September 30, 2022, we had net income of $1,642,459, which is driven by an unrealized gain of $1,216,614 on our warrants and $1,151,217 in interest income from investments held in our Trust Account. Partially offsetting our income is operating costs and of $488,099 and provision for income tax of $237,273.

For the nine months ended September 30, 2022, we had net income of $6,282,956, which is driven by an unrealized gain of $6,423,387 on our warrants and $1,418,183 in interest income from investments held in our Trust Account. Partially offsetting our income is operating costs and of $1,304,376 and provision for income tax of $254,238.

For the three months ended September 30, 2021, we had net income of $5,658,942, which is driven by an unrealized gain of $6,088,400 and $21,434 in interest income from investments held in our Trust Account, partially offset by $450,892 in formation and operating costs.

For the nine months ended September 30, 2021, we had net income of $7,952,957, which is driven by an unrealized gain of $9,599,733 on our warrants and $58,469 in interest income from investments held in our Trust Account. Partially offsetting our income is $1,050,199 in formation and operating costs and warrant issue costs of $655,046.

Going Concern

We have approximately $28,000 in cash and approximately $1,300,000 in current liabilities as of September 30, 2022 and have incurred and expects to incur additional significant costs in pursuit of financing and acquisition plans. Additionally, we have until February 11, 2023 to consummate a Business Combination. In connection with our assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements– Going Concern,” we have determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about our ability to continue as a going concern. We intend to complete a Business Combination before the mandatory liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after February 11, 2023.

Contractual Obligations

Administrative Services Agreement

Commencing on the date that our securities are first listed on the Nasdaq Stock Market, we agreed to pay the Sponsor up to $25,000 per month for administrative and other services, of which $10,000 per month will be paid to the Sponsor for office space and administrative services provided to members of the management team and up to $15,000 will be used to compensate the Company’s Chief Operating Officer and Chief Financial Officer and Secretary for a portion of their time spent on the Company’s affairs. Upon completion of the Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees.

Registration Rights

The initial stockholders and holders of the Private Placement Warrants will be entitled to registration rights pursuant to a registration rights agreement. The initial stockholders and holders of the Private Placement Warrants will be entitled to make up to three demands, excluding short form registration demands, that register such securities for sale under the Securities Act. In addition, these holders will have “piggy-back” registration rights to include their securities in other registration statements filed by us. We will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

We granted the underwriters a 45-day option to purchase up to 3,600,000 additional Units to cover any over-allotments, at the initial public offering price less the underwriting discounts and commissions. The warrants that were issued in connection with the 3,600,000 over-allotment Units are identical to the public warrants and have no net cash settlement provisions.

We paid an underwriting discount of 2% of the per Unit offering price, or approximately $5,520,000 million in the aggregate at the closing of the Initial Public Offering, and agreed to pay an additional fee (the “Deferred Underwriting Fees”) of 3.5% of the gross offering proceeds, or approximately $9,660,000 in the aggregate upon the Company’s completion of an Initial Business Combination. The Deferred Underwriting Fees will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes its initial Business Combination.

23

Table of Contents

Critical Accounting Policies

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have not identified any critical accounting policies.

Derivative Financial Instruments

We evaluate our financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. We have determined the warrants are a derivative instrument.

FASB ASC 470-20, Debt with Conversion and Other Options addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. We apply this guidance to allocate IPO proceeds from the Units between Class A common stock and warrants, using the residual method by allocating IPO proceeds first to fair value of the warrants and then the Class A common stock.

Investments Held in the Trust Account

Our portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on marketable securities, dividends and interest held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account were determined using available market information.

Class A Common Stock Subject to Possible Redemption

We account for Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. Our Class A common stock features certain redemption rights that is considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ (deficit) equity section of the condensed balance sheets.

Net Income Per Share

We have two classes of common shares, which are referred to as Class A common stock and Class B common stock. Earnings and losses are shared pro rata between the two classes of stock. Private and public warrants to purchase 14,480,000 Class A common stock at $11.50 per share were issued on February 8, 2021. No warrants were exercised during the three and nine months ended September 30, 2022 and 2021. The calculation of diluted income per common share does not consider the effect of the warrants issued in connection with the (i) IPO, (ii) exercise of over-allotment, and (iii) Private Placement since the exercise of the warrants are contingent upon the occurrence of future events. As a result, diluted net income per common share is the same as basic net income per common share for the periods. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.

24

Table of Contents

Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. ASU 2016-13 also requires additional disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. The Company expects to adopt the provisions of this guidance on January 1, 2023. The adoption is not expected to have a material impact on the Company’s condensed financial statements.

Besides the above, the Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Off-Balance Sheet Arrangements

As of September 30, 2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

Inflation

We do not believe that inflation had a material impact on our business, revenues or operating results during the period presented.

JOBS Act

The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, the financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

​

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

​

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

25

Table of Contents

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2022. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective. Accordingly, management believes that the financial statements included in this Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the period presented.

Remediation of a Material Weakness in Internal Control over Financial Report

We recognize the importance of the control environment as it sets the overall tone for the Company and is the foundation for all other components of internal control. Consequently, we designed and implemented remediation measures to address the material weakness previously identified and enhance our internal control over financial reporting. In light of the material weakness, we enhanced our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our condensed financial statements, including providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

​

26

Table of Contents

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

None.

​

Item 1A. Risk Factors.

Factors that could cause our actual results to differ materially from those in this Quarterly Report on Form 10-Q are any of the risks described in our Form 10-K for the year ended December 31, 2021 as filed with the SEC on March 25, 2022. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.

​

In addition, on March 30, 2022, the SEC issued proposed rules relating to, among other items, enhancing disclosures in business combination transactions involving special purpose acquisition companies and private operating companies; amending the financial statement requirements applicable to transactions involving shell companies; enhancing disclosures regarding projections in SEC filings in connection with proposed business combination transactions; increasing the potential liability of certain participants in proposed business combination transactions; and the extent to which special purpose acquisition companies could become subject to regulation under the Investment Company Act of 1940. These rules, if adopted, whether in the form proposed or in revised form, may materially adversely affect our ability to engage financial and capital market advisors, negotiate and complete our initial business combination and may increase the costs and time relate thereto.

​

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On December 17, 2020, our Sponsor purchased an aggregate of 5,750,000 founder shares for a purchase price of $25,000, or approximately $0.004 per share, of which up to 900,000 shares were subject to forfeiture if the over-allotment option was not exercised by the underwriters in full. As a result of the underwriters’ election to fully exercise of their over-allotment option, the 900,000 shares are no longer subject to forfeiture. On February 8, 2021, as part of an upsizing of our initial public offering, we effected a stock split in which each issued share of Class B common stock that was outstanding was converted into one and two tenths shares of Class B common stock, resulting in an aggregate of 6,900,000 shares of Class B common stock issued and outstanding.

Prior to the initial investment in the company of $25,000 by our Sponsor, the Company had no assets, tangible or intangible. The per share price was determined by dividing the amount of cash contributed to the company by the number of founder shares issued.

Our Sponsor is an accredited investor for purposes of Rule 501 of Regulation D. Each of the equity holders in our Sponsor is an accredited investor under Rule 501 of Regulation D. The sole business of our Sponsor is to act as the Company’s sponsor in connection with this offering. The limited liability company agreement of our Sponsor provides that its membership interests may only be transferred to our officers or directors or other persons affiliated with our Sponsor, or in connection with estate planning transfers.

Substantially concurrently with the closing of our Initial Public Offering, pursuant to the Private Placement Warrants Purchase Agreement, the Company completed the private sale of an aggregate of 5,213,333 warrants (the “Private Placement Warrants”) to our Sponsor at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $7,820,000. The Private Placement Warrants are identical to the Warrants sold in the Initial Public Offering, except that the Private Placement Warrants, so long as they are held by our Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of such Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by such holders until 30 days after the completion of the Company’s initial business combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

On June 28, 2021, the Sponsor elected to convert $100,000 of outstanding principal amount under the Working Capital Loans into, and the Company has issued, warrants to purchase 66,6667 shares of Class A common stock of the Company at a purchase price of $11.50 per share, subject to adjustment as described in the Private Placement Warrants Purchase Agreement. Such warrants are identical to the Private Placement Warrants issued to the Sponsor in connection with our Initial Public Offering. The issuance of such warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

​

27

Table of Contents

Item 3. Defaults upon Senior Securities.

None.

​

Item 4. Mine Safety Disclosures.

Not applicable.

​

Item 5. Other Information.

None.

​

Item 6. Exhibits.

​

Exhibit Number |  | Description
31.1* | ​ | Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
​ | ​ | ​
31.2* | ​ | Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
​ | ​ | ​
32.1** | ​ | Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
​ | ​ | ​
32.2** | ​ | Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
​ | ​ | ​
101.INS | ​ | XBRL Instance Document
​ | ​ | ​
101.SCH | ​ | XBRL Taxonomy Extension Schema Document
​ | ​ | ​
101.CAL | ​ | XBRL Taxonomy Extension Calculation Linkbase Document
​ | ​ | ​
101.DEF | ​ | XBRL Taxonomy Extension Definition Linkbase Document
​ | ​ | ​
101.LAB | ​ | XBRL Taxonomy Extension Label Linkbase Document
​ | ​ | ​
101.PRE | ​ | XBRL Taxonomy Extension Presentation Linkbase Document
​ | ​ | ​
104 | ​ | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

* | Filed herewith.

** | These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

​

28

Table of Contents

PART III

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

​ | By: | /s/ Oleg Grodnensky
​ | ​ | Name: | Oleg Grodnensky
​ | ​ | Title: | Chief Financial Officer

​

Dated: November 14, 2022

​

29